US Medical Supply Facility: North Carolina Opening
- A new manufacturing facility has commenced operations in Dallas, N.C., to ramp up domestic production of materials essential for pipette tips, according to the administration for Strategic Preparedness...
- The facility is projected to produce 1,210 tons of Carbon Black each month.
- The ASPR previously awarded $80 million to Premix Oy, a manufacturer, to facilitate the opening of this facility.
The US medical supply chain just got a shot in the arm! A new facility in Dallas, North Carolina, has opened its doors, ready to significantly boost domestic production of pipette tip materials, vital components in diagnostics and life sciences.This strategic move aligns with national efforts to bolster the manufacture of medical supplies. The plant is set to produce a massive 1,210 tons of Carbon Black monthly, a key ingredient for pipette tips, fueled by an $80 million investment. This initiative supports the resilience of the US medical apparatus, improving testing and drug advancement capabilities. News directory 3 will be watching as this ramp-up progresses. Discover what’s next for US medical manufacturing.
North Carolina Facility Aims to Boost Pipette Tip Production
Updated June 10, 2025
A new manufacturing facility has commenced operations in Dallas, N.C., to ramp up domestic production of materials essential for pipette tips, according to the administration for Strategic Preparedness and Response (ASPR). Pipette tips are critical components used extensively in diagnostics and life sciences.
The facility is projected to produce 1,210 tons of Carbon Black each month. This medical-grade compound is a key ingredient in pipette tips, which are vital for disease testing, blood sample analysis, and drug development.
The ASPR previously awarded $80 million to Premix Oy, a manufacturer, to facilitate the opening of this facility. This initiative supports efforts to incentivize domestic manufacturing of drugs and medical supplies.
What’s next
The increased production of pipette tip materials is expected to enhance the reliability of the U.S.medical supply chain and support ongoing efforts in disease testing and drug development.